Understanding Your Treatment Transition Options
Why Patients Consider Changing From Wegovy To Mounjaro
The decision to change from Wegovy to Mounjaro typically stems from individual treatment responses and tolerability factors. Wegovy (semaglutide) works as a GLP-1 receptor agonist, mimicking natural fullness hormones to reduce appetite and promote satiety. Mounjaro (tirzepatide) functions as a dual GIP/GLP-1 receptor agonist, potentially offering different side effect profiles and treatment responses for some patients.
Both medications are prescription-only medicines requiring clinical assessment and ongoing medical supervision. Your prescriber will evaluate factors including your current treatment response, side effect experience, medical history, and individual treatment goals when considering any medication change. The transition process requires careful planning to ensure continuity of care and optimal treatment outcomes throughout your weight management journey.
Wegovy Starter Dose Pricing and Treatment Options
If you're exploring a change from Wegovy to Mounjaro, understanding current Wegovy pricing helps inform your treatment decisions. Our Wegovy 0.25mg starter dose costs £79.99 for new customers using code FIRST40 at checkout, while returning customers can use code DOSE25. The complete dose escalation schedule includes 0.5mg at £94.99, 1mg at £99.99, 1.7mg at £139.99, and the maintenance 2.4mg dose at £209.99.
For patients beginning their weight management journey, our Intro Duo bundle combines the 0.25mg and 0.5mg doses for £169.99, providing eight weeks of initial treatment. This approach ensures treatment continuity while allowing you to assess your individual response to semaglutide therapy before considering any potential medication changes with your prescriber's guidance.
Clinical Evidence Supporting Treatment Decisions
When considering a change from Wegovy to Mounjaro, clinical evidence helps inform treatment decisions. In the STEP clinical trials, patients taking Wegovy alongside diet and exercise experienced an average weight loss of approximately 15% at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP programme demonstrated consistent efficacy across different patient populations and treatment settings.
Mounjaro's clinical evidence comes from the SURMOUNT trial programme, showing different efficacy profiles due to its dual mechanism of action. However, direct comparisons between trial results aren't clinically meaningful due to different study designs, patient populations, and endpoints. Your prescriber can evaluate which treatment approach may be most suitable based on your individual circumstances and medical history.
How Wegovy Works in Weight Management
Understanding Wegovy's mechanism helps patients considering a change from Wegovy to Mounjaro make informed decisions. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the action of incretin hormones naturally produced in your intestine. These hormones signal fullness to your brain after eating, helping reduce appetite and food cravings. The medication works on appetite centres in your brain, promoting feelings of satiety with smaller meal portions. This mechanism supports weight management when used alongside a reduced-calorie diet and increased physical activity. The once-weekly injection provides consistent therapeutic levels throughout the week, supporting sustained appetite control.
EverydayMeds Ordering Process and Clinical Support
Our streamlined process supports patients considering a change from Wegovy to Mounjaro with comprehensive clinical oversight. Begin with our 3-minute online clinical assessment, providing detailed information about your current treatment, medical history, and weight management goals. Our qualified prescribers review your assessment within 3 working days (or 24 hours with express service), ensuring thorough evaluation of your treatment needs. Once approved, your medication ships via next-day delivery using temperature-controlled cold-chain logistics to maintain medication integrity. Our GPhC-registered pharmacy service (#9012878) ensures all treatments meet stringent UK regulatory standards. Throughout your treatment journey, our clinical team remains available for ongoing support and guidance.
Storage Requirements and Practical Considerations
Proper storage is crucial when managing a change from Wegovy to Mounjaro, as both medications have specific requirements. Wegovy must be stored in the refrigerator at 2-8°C before first use, but offers a significant travel advantage with up to 6 weeks of room temperature storage below 30°C once removed from the fridge. This compares favourably to Mounjaro's 21-day room temperature limit, making Wegovy more convenient for travel or lifestyle flexibility. The FlexTouch pen design provides easy once-weekly self-injection with pre-filled, single-use cartridges. Dose escalation follows a mandatory 16-week schedule starting with 0.25mg, and patients cannot skip doses as this affects both safety and treatment effectiveness. Each pen contains four weekly doses, requiring a new pen each month during the escalation phase.
Personalised Treatment Transition Planning
Successfully managing a change from Wegovy to Mounjaro requires individualised clinical planning based on your specific circumstances. Factors influencing transition decisions include current dose level, treatment duration, side effect experience, and therapeutic response to date. Your prescriber will evaluate the optimal timing for any medication change, considering washout periods and gradual transition protocols to minimise disruption to your weight management progress.
Both medications require ongoing lifestyle modifications including reduced-calorie diet and increased physical activity for optimal effectiveness. The transition period may involve temporary adjustments to your routine as your body adapts to different medication mechanisms. Professional guidance ensures continuity of care and maintains momentum in your weight management journey throughout any treatment changes.
Making Your Treatment Decision With Expert Support
At EverydayMeds, we understand that considering a change from Wegovy to Mounjaro represents an important decision in your weight management journey. Both medications are available through our service, allowing your prescriber to recommend the most appropriate option based on your individual needs and clinical profile. New customers can access Wegovy 0.25mg starter dose for £79.99 using code FIRST40, while returning customers use code DOSE25 at checkout. Our clinical team provides ongoing support throughout your treatment, whether continuing with Wegovy or transitioning to alternative therapies. Contact our GPhC-registered pharmacy (#9012878) to discuss your options and begin your personalised treatment plan today.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
